Table 2
Calibration parameters to adjust baseline survival of screen-detected non-small-cell cancers to match stage-specific survival curves and reported mortality reductions in National Lung Screening Trial (NLST)
Stage of screen-detected cancer | Relative risk applied to baseline survival | Lead-time redistribution scalarsNote * |
---|---|---|
I | 0.8 | 1.3 |
II | 1 | 0.4 |
III | 1 | 0.3 |
IV | 1 | 0.25 |
|
Report a problem on this page
Is something not working? Is there information outdated? Can't find what you're looking for?
Please contact us and let us know how we can help you.
- Date modified: